565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

A.J. ten Tije; C. Seynaeve; J.H. Schornagel; J.C. Pouget; B. Laffranchi; G. Blanchot; J. Lieverst; J. ter Steg; J. Verweij; J.H.M. Schellens

doi:10.1016/s1359-6349(03)90597-0

565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

A.J. ten Tije, C. Seynaeve, J.H. Schornagel, J.C. Pouget, B. Laffranchi, G. Blanchot, J. Lieverst, J. ter Steg, J. Verweij, J.H.M. Schellens

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

Originele taal-2	Nederlands
Pagina's (van-tot)	S171
Tijdschrift	European Journal of Cancer Supplements
Volume	1
Nummer van het tijdschrift	5
DOI's	https://doi.org/10.1016/s1359-6349(03)90597-0
Status	Gepubliceerd - sep. 2003

Toegang tot document

10.1016/s1359-6349(03)90597-0

Citeer dit

ten Tije, A. J., Seynaeve, C., Schornagel, J. H., Pouget, J. C., Laffranchi, B., Blanchot, G., Lieverst, J., ter Steg, J., Verweij, J., & Schellens, J. H. M. (2003). 565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC). European Journal of Cancer Supplements, 1(5), S171. https://doi.org/10.1016/s1359-6349(03)90597-0

@article{9a323d0de448401fa3bccad305870c5a,

title = "565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)",

author = "{ten Tije}, A.J. and C. Seynaeve and J.H. Schornagel and J.C. Pouget and B. Laffranchi and G. Blanchot and J. Lieverst and {ter Steg}, J. and J. Verweij and J.H.M. Schellens",

year = "2003",

month = sep,

doi = "10.1016/s1359-6349(03)90597-0",

language = "Nederlands",

volume = "1",

pages = "S171",

journal = "European Journal of Cancer Supplements",

number = "5",

}

ten Tije, AJ, Seynaeve, C, Schornagel, JH, Pouget, JC, Laffranchi, B, Blanchot, G, Lieverst, J, ter Steg, J, Verweij, J & Schellens, JHM 2003, '565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)', European Journal of Cancer Supplements, vol. 1, nr. 5, blz. S171. https://doi.org/10.1016/s1359-6349(03)90597-0

TY - JOUR

T1 - 565 Phase I combination study of oral vinorelbine (VRL) and oral cyclophosphamide (CTX) in patients with metastatic breast cancer (MBC)

AU - ten Tije, A.J.

AU - Seynaeve, C.

AU - Schornagel, J.H.

AU - Pouget, J.C.

AU - Laffranchi, B.

AU - Blanchot, G.

AU - Lieverst, J.

AU - ter Steg, J.

AU - Verweij, J.

AU - Schellens, J.H.M.

PY - 2003/9

Y1 - 2003/9

UR - https://www.mendeley.com/catalogue/5fce3fa5-d375-3e86-8a40-78f654673e82/

U2 - 10.1016/s1359-6349(03)90597-0

DO - 10.1016/s1359-6349(03)90597-0

M3 - Artikel

VL - 1

SP - S171

JO - European Journal of Cancer Supplements

JF - European Journal of Cancer Supplements

IS - 5

ER -